Ryan D. Maynard
2014
In 2014, Ryan D. Maynard earned a total compensation of $1.1M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Option Awards | $653,575 |
|---|---|
| Salary | $441,345 |
| Other | $3,006 |
| Total | $1,097,926 |
Maynard received $653.6K in option awards, accounting for 60% of the total pay in 2014.
Maynard also received $441.3K in salary and $3K in other compensation.
Rankings
In 2014, Ryan D. Maynard's compensation ranked 7,173rd out of 13,032 executives tracked by ExecPay. In other words, Maynard earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,173 out of 13,032 | 45th |
Division Manufacturing | 2,639 out of 4,965 | 47th |
Major group Chemicals And Allied Products | 899 out of 1,690 | 47th |
Industry group Drugs | 706 out of 1,369 | 48th |
Industry Pharmaceutical Preparations | 542 out of 1,042 | 48th |
Source: SEC filing on March 29, 2017.
Maynard's colleagues
We found five more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2014.
2014
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2014
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, of Discovery and Research
2014
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2014
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2014
Dolly Vance
Rigel Pharmaceuticals